IPOTracker
eToroTrade IPO stocks the day they listStart on eToro
All companies
Alamar Biosciences Inc logo

Alamar Biosciences Inc

ALMR
PublicArchived
Public / ArchivedUnited StatesUSUnited States(Nasdaq)Best valuation $1.95B1 market

Public listing

Listed· Nasdaq· Listing market: United StatesUS United States
Listing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available

Sources: sec-harvest, nasdaq

IPO Calendar
IPO Calendar · NasdaqIPO
ALMR
Price
$28.10
24h
-0.88%
Valuation
$1.95B
24h volume
$6.92M
Type
IPO
IPO CalendarTrade Alamar Biosciences Inc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 1h ago

Alamar Biosciences Inc IPO unlock schedule & public float

Lock-up schedule, public float and locked shares extracted from Alamar Biosciences Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4Apr 17, 2026
Total shares (FD)
66.52M
Public float
11.25M
Locked
55.27M
IPO raise
$191.25M
Next unlock
Oct 14, 2026 · 55.27M
Shares eligible to trade · by holder groupApr 17, 2026 → Oct 14, 2026 · 100% unlocked
  • Lock-up holders55.27M
  • IPO public float11.25M
Supply pressure · next 90 daysHigh

Up to 55.27M shares (~4.9× the current float) become eligible within 90 days. Eligible shares within 90 days dwarf the current float. Staggered by design — eligible does not mean sold.

About Alamar Biosciences Inc

Alamar Biosciences Inc is a life-sciences tools company developing precision proteomics technology for biomarker discovery and disease research.

What the company does

  • Develops immunoassay and proteomics platforms intended to detect and analyze low-abundance proteins.
  • Serves researchers, biopharma companies, and clinical-development teams that need sensitive biological measurement tools.
  • Competes on assay sensitivity, throughput, workflow reliability, data quality, and adoption by research and translational-medicine customers.

Business profile

Alamar Biosciences sits in the life-sciences tools market, where platform performance, installed-base growth, consumables pull-through, and research-budget demand shape the business.

SEC IPO filings

Effective

EDGAR filings resolved from ALMR / CIK 0002104204.

424B4424B4
Apr 17, 2026Final prospectus0001193125-26-161647
S-1/AS-1/A
Apr 16, 2026Amended0001193125-26-158122
8-A12B8-A12B
Apr 15, 2026Exchange registration0001193125-26-156986
S-1/AS-1/A
Apr 13, 2026Amended0001193125-26-151891
S-1S-1
Mar 27, 2026Filed0001193125-26-129039
DRS/Afilename1.htm
Mar 12, 2026Confidential draft0001193125-26-104470
DRS/Afilename1.htm
Feb 17, 2026Confidential draft0001193125-26-054940
DRSfilename1.htm
Jan 9, 2026Confidential draft0001193125-26-009127

Alamar Biosciences Inc IPO — frequently asked questions

When did Alamar Biosciences Inc go public?
Alamar Biosciences Inc has already gone public and now trades publicly on Nasdaq under the ticker ALMR.
Can I buy Alamar Biosciences Inc stock?
Yes — Alamar Biosciences Inc is publicly traded on Nasdaq as ALMR. You can follow its live price, valuation and post-IPO performance above.
What is Alamar Biosciences Inc's valuation?
Alamar Biosciences Inc's most recent valuation tracked here is $1.95B, derived from live market prices.